Globus Medical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.About GMED
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders.
CEOKeith W. Pfeil
CEOKeith W. Pfeil
Employees5,300
Employees5,300
HeadquartersAudubon, Pennsylvania
HeadquartersAudubon, Pennsylvania
Founded2003
Founded2003
Employees5,300
Employees5,300
GMED Key Statistics
Market cap12.26B
Market cap12.26B
Price-Earnings ratio28.88
Price-Earnings ratio28.88
Dividend yield—
Dividend yield—
Average volume1.59M
Average volume1.59M
High today$89.99
High today$89.99
Low today$88.52
Low today$88.52
Open price$89.25
Open price$89.25
Volume1.28M
Volume1.28M
52 Week high$94.93
52 Week high$94.93
52 Week low$51.79
52 Week low$51.79
Stock Snapshot
As of today, Globus Medical(GMED) shares are valued at $88.58. The company's market cap stands at 12.26B, with a P/E ratio of 28.88.
On 2025-12-24, Globus Medical(GMED) stock moved within a range of $88.52 to $89.99. With shares now at $88.58, the stock is trading +0.1% above its intraday low and -1.6% below the session's peak.
Trading volume for Globus Medical(GMED) stock has reached 1.28M, versus its average volume of 1.59M.
The stock's 52-week range extends from a low of $51.79 to a high of $94.93.
The stock's 52-week range extends from a low of $51.79 to a high of $94.93.
GMED News
TipRanks 7d
Globus Medical Advances Clinical Study on REFLECT™ Scoliosis SystemGlobus Medical (GMED) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level d...
Analyst ratings
56%
of 16 ratingsBuy
56.3%
Hold
37.5%
Sell
6.3%
People also own
Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.